Lead sponsor
Forest Laboratories
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
1,451
Total enrollment
135
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
3
Phase 4
2
Trials by status
Completed
5
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's DiseaseAlzheimer's diseasePh 3Completed677
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseAlzheimer's diseasePh 3Completed400
Effect of Memantine on Functional Communication in Patients With Alzheimer's DiseaseAlzheimer's diseasePh 4Completed265
Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)Alzheimer's diseasePh 4Completed75
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's DiseaseAD symptomatic therapy: stable ≥3 monthsPh 3Completed34